FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

Share FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Sign up to save your podcasts

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease